Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 39,764 |
|
|||||
| News | - | ||||||
| Day High | 0.85 | Low High |
|||||
| Day Low | 0.77 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| YS Biopharma Company Ltd | YS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.005 | 0.63% | 0.80 | 23:00:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.77 | 0.77 | 0.85 | 0.80 | 0.795 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 188 | 39,764 | US$ 0.799045 | US$ 31,773 | - | 0.3503 - 1.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:13:56 | 2 | US$ 0.8196 | USD |
YS Biopharma Company Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.44M | 93.06M | - | 687.2M | -283.47M | -3.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
YS Biopharma News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.80 | 0.88 | 0.70 | 0.745198 | 131,335 | 0.00 | 0.00% |
| 1 Month | 0.72 | 1.0285 | 0.70 | 0.8452759 | 178,054 | 0.08 | 11.11% |
| 3 Months | 0.40 | 1.0285 | 0.3503 | 0.6091046 | 211,582 | 0.40 | 100.00% |
| 6 Months | 0.4303 | 1.0285 | 0.3503 | 0.5621641 | 163,256 | 0.3697 | 85.92% |
| 1 Year | 1.42 | 1.97 | 0.3503 | 1.21 | 505,613 | -0.62 | -43.66% |
| 3 Years | 12.67 | 12.93 | 0.3503 | 1.40 | 587,593 | -11.87 | -93.69% |
| 5 Years | 12.67 | 12.93 | 0.3503 | 1.40 | 587,593 | -11.87 | -93.69% |
YS Biopharma Description
| YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. |
